Editor of Patient Care Online.
New Treatment Approved for Congenital Adrenal Hyperplasia: Daily Dose
Your daily dose of the clinical news you may have missed.
Smartphone App Shows Promise for Managing Hypertension in Observational Study
People with hypertension who adhered to the mobile app demonstrated well-controlled blood pressure over a 12-week observational period.
Atogepant Improves QoL in Chronic, Episodic Migraine: Daily Dose
Targeted Intervention Boosts Colorectal Cancer Screening Rates among Underserved US Adults
A centralized mailed FIT outreach intervention significantly improved CRC screening in a diverse patient population, according to recent data
Fremanezumab for Prevention of Episodic Migraine in Children: Daily Dose
Brexpiprazole and Sertraline Combination Therapy Shows Efficacy in Treating PTSD
New findings highlight the potential of this combination therapy as a new option for people with PTSD who have not responded to standard treatments.
US Adults Lagging in Flu, COVID-19, and RSV Vaccination: Daily Dose
10 Essential Vaccine Updates for Primary Care: Winter 2024-2025
From ACIP updates on age eligibility and research on vaccine efficacy to US adults' attitudes toward recommended shots, these 10 at-a-glance news briefs are must-reads for PCPs.
Future of Obesity Care: 3 Wishes from Thought Leader Donna Ryan, MD
When asked about her 3 wishes for the future of obesity care, Donna Ryan, MD, told Patient Care that she had just one: access.
Investigational Maridebart Cafraglutide Shows Promise for Obesity, T2D: Daily Dose
FDA Approves Nemolizumab for Treatment of Moderate-to-Severe Atopic Dermatitis
Nemolizumab is the first approved monoclonal antibody that targets IL-31 receptor alpha, inhibiting the signaling of IL-31, which drives disease mechanism in atopic dermatitis.
January Issue of Patient Care Online Digital Edition is Now Live
Find details on US colorectal cancer screening rates, dietary interventions for people with IBS, and research on the primary drivers of cost of IBD care.
Tirzepatide Superior to Semaglutide in Weight Loss Trial: Daily Dose
Expert Perspectives 2024: The Dynamic Future of Obesity Medicine, with Donna Ryan, MD
The future of obesity medicine is filled with promise as GLP-1 RAs and other peptides continue to demonstrate pluripotency in metabolic disease.
FDA Review Sought for Lumateperone as Adjunctive Therapy for Major Depressive Disorder
Intra-Cellular Therapies submitted an sNDA to the FDA for lumateperone for the treatment of MDD in adults as as adjunctive therapy to antidepressants.
Role of Sleep in Dementia and Associated Comorbidities: Daily Dose
Emerging Obesity Research to Watch For in 2025
Donna Ryan, MD, highlights exciting advancements in weight loss and metabolic treatments, particularly involving GLP-1 RAs and related therapies.
Antiobesity Drugs May Help Curb Alcohol Consumption: Daily Dose
The Evolving Perception and Utilization of Antiobesity Drugs: Expert Discussion
Donna Ryan, MD, highlights how the media has helped to reframe obesity as a chronic disease and how antiobesity drugs are transforming metabolic disease treatment.
Most US Adults Want Primary Care Physicians to Address Mental Health: Daily Dose
Pivotal Obesity Trials in 2024: A Conversation with Donna Ryan, MD
Donna Ryan, MD, discusses the most significant clinical trials published this year in the field of obesity medicine.
Online UTI Myths Found Common, Dangerous: Daily Dose
FDA Accepts GSK’s Submission for Use of Mepolizumab in COPD
The Prescription Drug User Fee Act date is set for May 7, 2025.
More than Half of US Adults Eligible for Semaglutide: Daily Dose
Preventing Colon Cancer Before It Starts: Researchers Explore Novel Therapeutic Strategies
William Grady, MD, talks about the latest research in colorectal cancer, including treatments targeting senescent cells that contribute to tumor formation.
Influenza Antiviral Treatment Underutilized Among Vulnerable Youth: Daily Dose
Exercise of Any Level Cuts Mortality Risk in People with Dementia: Daily Dose
Flu, COVID-19, RSV Vaccine Uptake Low Among US Adults in 2024-2025 Season
Many unvaccinated adults reported intent to get vaccinated, according to early season estimates released in MMWR.
Investigational Drug Reduces Lp(a) in High-Risk Adults: Daily Dose
Antiobesity Medications May Help Lower Alcohol Use, New Study Suggests
In a study of adults enrolled in a telehealth weight management program, 45% decreased their alcohol use after taking antiobesity medication.
